buserelin has been researched along with Atypical Ductal Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Astone, A; Barone, C; Cassano, A; Garufi, C; Noviello, MR; Pietrantonio, F | 1 |
| Barni, S; Cattaneo, G; Crispino, S; Lissoni, P; Tancini, G | 1 |
2 other study(ies) available for buserelin and Atypical Ductal Hyperplasia
| Article | Year |
|---|---|
A response in advanced post-menopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist--Zoladex.
Topics: Aged; Breast Neoplasms; Buserelin; Carcinoma, Intraductal, Noninfiltrating; Female; Goserelin; Humans; Menopause | 1989 |
Endocrine and clinical effects of an LHRH analogue in pretreated advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Buserelin; Carcinoma, Intraductal, Noninfiltrating; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Prolactin; Testosterone | 1988 |